ZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with a variable clinical course and overall survival times ranging from months to decades.[1][1] Mutational status of immunoglobulin heavy chain variable region (IGHV) correlates with clinical behavior and is a powerful prognostic factor